The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Quintiles is resuming its plans to raise more than $2 billion in bank financing.
The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
In early 2009, six medical professional societies got together to write a guide for 180 cardiac revascularization procedures.
A recent survey, however, shows that there may not be consensus amongst the doctors who practice the surgical and percutaneous coronary intervention procedures.
Medtronic Inc. (NYSE:MDT) launched two pacemakers that had been delayed by regulatory snafus for months, the company said today.
The Fridley, Minn.-based company resolved a Nov. 2009 warning letter that enabled the company to win FDA approval for the Consulta and Syncra cardiac resynchronization therapy-pacemaker (CRT-P) systems.
Here’s a roundup of companies announcing new distribution deals.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Pacific Biosciences of California Inc. (NSDQ:PACB) won a favorable decision from the U.S. Patent Office over a competitor.
The Menlo Park, Calif.-based company began a "patent interference" process against Life Technologies Corp. (NSDQ:LIFE) in March 2009 regarding patent claims by both companies on single-molecule sequencing technology.
The Federal Trade Commission will force the sale of MDS Inc.’s (NYSE:MDZ) laser-microdissection unit to Life Technologies Corp. (NSDQ:LIFE) after Danaher Corp. (NYSE:DHR) completes its $650 million buyout of MDS.
The anti-trust watchdog wants to make sure that two of the four North American suppliers of the devices don’t wind up under the same corporate roof, according to Dow Jones Newswires.
Illumina Inc. (NSDQ:ILMN) put some distance between itself and its competitors this week, as it revealed equipment capable of sequencingthe human genome for less than $10,000.
The San Diego-based company unveiled its HiSeq 2000 at the annual J.P. Morgan Health Care Conference in San Francisco, where CEO Jay Flatley said a Hong Kong-based genomics institute called BGI bought 128 of the $690,000 systems, according to the Wall Street Journal.
